Inhibitors of bombesin-stimulated intracellular signals: interruption of an autocrine pathway as a therapeutic strategy in small cell lung carcinoma.
作者信息
Sausville E A, Trepel J B, Moyer J D
机构信息
NCI-Navy Medical Oncology Branch, Bethesda, MD.
出版信息
Prog Clin Biol Res. 1990;354A:193-207.
PMID:2174173
Abstract
摘要
相似文献
1
Inhibitors of bombesin-stimulated intracellular signals: interruption of an autocrine pathway as a therapeutic strategy in small cell lung carcinoma.
Prog Clin Biol Res. 1990;354A:193-207.
2
Bombesin-like peptides as growth factors.
Wien Klin Wochenschr. 1989 Jun 23;101(13):435-40.
3
Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Cancer Res. 1988 Sep 1;48(17):4783-9.
4
Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
J Cell Biochem. 1989 Aug;40(4):431-7. doi: 10.1002/jcb.240400404.
5
Effects of bombesin on growth of human small cell lung carcinoma in vivo.
Cancer Res. 1988 Mar 15;48(6):1439-41.
6
In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinoma.
Anticancer Res. 1993 Jan-Feb;13(1):75-9.
7
Protein kinase C is not involved in the homologous desensitization of bombesin responses in small cell lung cancer cells.
Exp Cell Res. 1993 Dec;209(2):398-401. doi: 10.1006/excr.1993.1327.
8
Autocrine growth factors in human small cell lung cancer.
Cancer Surv. 1985;4(4):707-27.
9
Gastrointestinal peptide signalling in health and disease.
Eur J Surg Suppl. 2002(587):23-38.
10
Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer.
Br J Cancer. 1988 Jun;57(6):579-86. doi: 10.1038/bjc.1988.132.
引用本文的文献
1
Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):2617-22. doi: 10.1073/pnas.1222355110. Epub 2013 Jan 28.
Zotero 插件